Results


Brain manipulation may boost confidence: Study

#artificialintelligence

Researchers in Japan are using a state-of-the-art technique to read and then amplify self-confidence in study participants. Dr. Mitsuo Kawato, director of the Computational Neuroscience Laboratories at the Advanced Telecommunications Research Institute International in Kyoto, Japan, has pioneered the process called "Decoded Neurofeedback." The technique used brain scanning to monitor and detect the occurrence of specific complex patterns of activity tied to high self-confidence states, while 17 participants performed a simple perceptual task. Whenever a pattern of high confidence was detected, participants received a small monetary reward. By doing this, researchers were able to directly boost a person's own confidence unconsciously, meaning the participants were unaware of the manipulation taking place.


New AI Mental Health Tools Beat Human Doctors at Assessing Patients

#artificialintelligence

About 20 percent of youth in the United States live with a mental health condition, according to the National Institute of Mental Health. The good news is that mental health professionals have smarter tools than ever before, with artificial intelligence-related technology coming to the forefront to help diagnose patients, often with much greater accuracy than humans. A new study published in the journal Suicide and Life-Threatening Behavior, for example, showed that machine learning is up to 93 percent accurate in identifying a suicidal person. The research, led by John Pestian, a professor at Cincinnati Children's Hospital Medical Center, involved 379 teenage patients from three area hospitals. Each patient completed standardized behavioral rating scales and participated in a semi-structured interview, answering five open-ended questions such as "Are you angry?" to stimulate conversation, according to a press release from the university.


IBM & Broad Institute Launch Major Research Initiative

#artificialintelligence

CAMBRIDGE, MA - 10 Nov 2016: IBM Watson Health (NYSE: IBM) and the Broad Institute of MIT and Harvard today announced a research initiative aimed at discovering the basis of cancer drug resistance. The five year, $50 million project will study thousands of drug resistant tumors and draw on Watson's computational and machine learning methods to help researchers understand how cancers become resistant to therapies. The anonymized data will be made available to the scientific community to catalyze research worldwide. IBM Watson Health and the Broad Institute bring the data prowess of Watson to study cancer drug resistance in a $50M research collaboration. The goal is to identify patterns that could reveal clues into one of the greatest medical mysteries of cancer.


New AI Mental Health Tools Beat Human Doctors at Assessing Patients

#artificialintelligence

About 20 percent of youth in the United States live with a mental health condition, according to the National Institute of Mental Health. The good news is that mental health professionals have smarter tools than ever before, with artificial intelligence-related technology coming to the forefront to help diagnose patients, often with much greater accuracy than humans. A new study published in the journal Suicide and Life-Threatening Behavior, for example, showed that machine learning is up to 93 percent accurate in identifying a suicidal person. The research, led by John Pestian, a professor at Cincinnati Children's Hospital Medical Center, involved 379 teenage patients from three area hospitals. Each patient completed standardized behavioral rating scales and participated in a semi-structured interview, answering five open-ended questions such as "Are you angry?" to stimulate conversation, according to a press release from the university.


Koninklijke Philips : Philips introduces new data-driven intelligent solutions connecting patients, practitioners and processes at the 2016 Radiological Society of North America Meeting 4-Traders

#artificialintelligence

Royal Philips (NYSE: PHG, AEX: PHIA) today unveiled a series of intelligent and comprehensive connected radiology solutions at the 2016 Radiological Society of North America Annual Meeting (RSNA), beginning November 27 through December 1 at McCormick Place in Chicago. At the Philips booth (#6735), RSNA attendees will experience a new portfolio of digital imaging systems, intelligent software and services to enhance diagnostics, improve patient care and operational efficiencies. Radiology is at the center of the majority of healthcare decisions, driving the timely detection and accurate diagnosis and treatment of disease at its earliest stages. As health organizations continue to move toward value-based care, they need intelligent solutions to meet the challenges they face in improving outcomes, lowering cost of healthcare delivery and enhancing patient satisfaction. "Radiologists are playing a pivotal role in determining the right path to the right treatment," said Robert Cascella, CEO, Diagnosis and Treatment, Philips.


New artificial intelligence technique could erase fear from your brain

#artificialintelligence

Imagine if your fear of spiders, heights or confined spaces vanished, leaving you with neutral feelings instead of a sweat-soaked panic. A team of neuroscientists said they found a way to recondition the human brain to overcome specific fears. Their approach, if proven in further studies, could lead to new ways of treating patients with phobias or post-traumatic stress disorder (PTSD). The international team published their findings Monday in the journal Nature Human Behaviour. About 19 million U.S. adults, or 8.7 percent of the adult population, suffer prominent and persistent fears at the sight of specific objects or in specific situations, according to the National Institute of Mental Health.


IBM & Broad Institute Launch Major Research Initiative

#artificialintelligence

CAMBRIDGE, MA - 10 Nov 2016: IBM Watson Health (NYSE: IBM) and the Broad Institute of MIT and Harvard today announced a research initiative aimed at discovering the basis of cancer drug resistance. The five year, $50 million project will study thousands of drug resistant tumors and draw on Watson's computational and machine learning methods to help researchers understand how cancers become resistant to therapies. The anonymized data will be made available to the scientific community to catalyze research worldwide. IBM Watson Health and the Broad Institute bring the data prowess of Watson to study cancer drug resistance in a $50M research collaboration. The goal is to identify patterns that could reveal clues into one of the greatest medical mysteries of cancer.


Frost & Sullivan Applauds Hindsait for Pioneering Healthcare-centric Artificial Intelligence

#artificialintelligence

"Hindsait's main goal has been to develop a robust, AI platform that specifically addresses the needs of healthcare organizations," said Frost & Sullivan Research Analyst Harpreet Singh Buttar. "This platform assists in reducing unnecessary health services, eliminating errors and biases in care delivery and improving overall quality of care." Hindsait's system has proven to be highly adaptable and scalable, based on unique use case requirements. Their capabilities range from natural language processing (NLP) and machine learning to cognitive computing and predictive analytics that directly helps providers and payers resolve healthcare delivery issues. Hindsait boasts a wide range of services, right from analyzing unstructured data, such as clinical notes, patient charts, and prescriptions, to real-time optimization of diagnostic and treatment plans.


IBM, Weather Co. bring Watson AI to ads

#artificialintelligence

IBM Watson has talked tennis with Serena Williams and music with Bob Dylan. Now it wants to talk to you -- via online ads. The Weather Company, acquired by IBM in January, will begin bringing Watson-enhanced interactive advertisements to The Weather Channel and Weather Underground apps on Android and iOS and to weather.com and wunderground.com The ads, powered by Watson's artificial intelligence, will prompt consumers to ask questions such as "What would be good to cook for dinner?" or "Is this medicine safe for my child?" The first companies with Watson-enabled ads will be Campbell Soup, GSK Consumer Healthcare and Unilever.


Vi Artificial Intelligence Personal Trainer Coaches You In Real-Time (video) - Geeky Gadgets

#artificialintelligence

If like me you can do with a little help and motivation when it comes to exercising correctly, you might be interested in a new artificial intelligence personal trainer called Vi. Which has already raised over 250,000 by the Kickstarter crowdfunding campaign and still has 47 days left remaining on its campaign. Vi has been designed by LifeBEAM and comes in the form of an AI personal trainer that is incorporated into bios sensing earphones and is capable of helping you take the correct path to help keep your body fit and healthy. Vi will coach you in real-time using the data which is fed back through the headphones. Check out the video below to learn more about this very unique personal trainer.